OSEBERG PHARMA AS

3128 NØTTERØY

Finances

Share Ownership

Return on Equity

−10,4 %

Current Ratio

5,28

Debt-to-Equity Ratio

−1,8

Key figures (NOK)	2022	2021	2020	2019
Revenue	57 000	480 000	4 005 000	0
Net Income	142 000	−1 543 000	501 000	−932 000
Total Assets	1 262 000	306 000	953 000	266 000
Total Equity	−1 365 000	−1 943 000	−400 000	−902 000

Income (NOK)	2022	2021	2020	2019
Revenue	57 000	480 000	4 005 000	0
Expenditure	−125 000	1 899 000	3 362 000	1 197 000
Operating Profit	182 000	−1 418 000	642 000	−1 197 000
Financial Income	0	0	5 000	0
Financial Costs	0	0	4 000	0
Financial Balance	0	0	1 000	0
Earnings Before Tax	182 000	−1 418 000	643 000	−1 197 000
Tax	40 000	124 000	141 000	−266 000
Net Income	142 000	−1 543 000	501 000	−932 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	396 000	0	124 000	266 000
Total Current Assets	866 000	306 000	829 000	0
Total Assets	1 262 000	306 000	953 000	266 000
Total Retained Equity	−1 395 000	−1 973 000	−430 000	−932 000
Total Equity	−1 365 000	−1 943 000	−400 000	−902 000
Total Long-Term Debt	2 463 000	2 136 000	1 280 000	0
Total Current Debt	164 000	113 000	73 000	1 167 000
Total Equity and Debt	1 262 000	306 000	953 000	266 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	57 000	480 000	4 005 000	0
Other Income	0	0	0	0
Revenue	57 000	480 000	4 005 000	0
Cost of Goods Sold	−139 000	668 000	1 535 000	647 000
Salary Costs	0	0	0	0
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	−125 000	1 899 000	3 362 000	1 197 000
Operating Profit	182 000	−1 418 000	642 000	−1 197 000
Financial Income	0	0	5 000	0
Financial Costs	0	0	4 000	0
Financial Balance	0	0	1 000	0
Dividends	0	0	0	0
Net Income	142 000	−1 543 000	501 000	−932 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	396 000	0	124 000	266 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	396 000	0	124 000	266 000
Stock	400 000	115 000	655 000	0
Total Investments	0	0	0	0
Cash, Bank	292 000	18 000	1 000	0
Total Current Assets	866 000	306 000	829 000	0
Total Assets	1 262 000	306 000	953 000	266 000
Total Equity	−1 365 000	−1 943 000	−400 000	−902 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	2 463 000	2 136 000	1 280 000	0
Creditors	7 000	132 000	−1 000	1 120 000
Unpaid Taxes	0	−19 000	25 000	0
Dividends	0	0	0	0
Other Current Debt	157 000	0	49 000	47 000
Total Current Debt	164 000	113 000	73 000	1 167 000
Total Equity and Debt	1 262 000	306 000	953 000	266 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−10,4 %	79,41 %	−125,25 %	103,33 %
Debt-to-Equity Ratio	−1,8	−1,1	−3,2	−0
Operating Profit Margin	319,3 %	−295,42 %	16,03 %	-
Current Ratio	5,28	2,71	11,36	0
Quick Ratio	−3,67	−153	−1,42	0
Equity Ratio	−1,08	−6,35	−0,42	−3,39
Gross Profit Margin	343,86 %	−39,17 %	61,67 %	-